PRESS RELEASE published on 02/16/2026 at 08:00, 7 months 15 days ago Axiodis CRO accelerates its sales and marketing strategy to support ambitious growth driven by Oxurion Axiodis CRO, a subsidiary of Oxurion Group, announces key developments in its growth strategy: recruiting sales & marketing roles, overhauling website, enhancing marketing strategy & targeting European market Growth Strategy European Market Clinical Data Management Axiodis CRO Oxurion Group
BRIEF published on 01/26/2026 at 18:05, 8 months 8 days ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Actions Transparency Sale Atlas Special Opportunities Oxurion
BRIEF published on 01/26/2026 at 18:05, 8 months 8 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities Digital Assets Transparency Notification Atlas Special Opportunities Oxurion Shares Threshold
PRESS RELEASE published on 01/26/2026 at 18:00, 8 months 8 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received transparency notification regarding shares crossing under the threshold due to sales of voting securities from Atlas Special Opportunities II, LLC. Company specializes in acquiring majority stakes in European pharmaceutical subcontractors Transparency Notification Belgium Oxurion NV Voting Securities European Pharmaceutical
BRIEF published on 01/23/2026 at 18:05, 8 months 11 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Shares Acquisition Atlas Special Opportunities Oxurion NV Pharmaceutical Subcontractors
BRIEF published on 01/23/2026 at 18:05, 8 months 11 days ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Health Oxurion
PRESS RELEASE published on 01/23/2026 at 18:00, 8 months 11 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification regarding a shareholder crossing the 10% threshold. The company specializes in acquiring stakes in pharmaceutical subcontractors Transparency Notification Shareholder Oxurion NV Belgian Transparency Legislation Pharmaceutical Subcontractors
BRIEF published on 01/19/2026 at 18:05, 8 months 15 days ago Oxurion Increases Share Capital Following Bond Conversion Shareholders Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
BRIEF published on 01/19/2026 at 18:05, 8 months 15 days ago Oxurion Announces Capital Increase Following Bond Conversion Ordinary Shares Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
PRESS RELEASE published on 01/19/2026 at 18:00, 8 months 15 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 2 convertible bonds in Oxurion, leading to EUR 50,000 capital increase. Oxurion discloses updated information on share capital and total number of securities after issuing new shares Share Capital Convertible Bonds Capital Increase Atlas Special Opportunities LLC Oxurion
Published on 10/02/2026 at 13:50, 1 day 13 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 14 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 14 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/03/2026 at 15:45, 11 hours 19 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 3 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 6 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 7 hours ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 9 hours ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 1 day 9 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/01/2026 at 19:00, 2 days 8 hours ago AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 8 hours ago Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 8 hours ago Covivio - Information on total number of voting rights and share capital